OTCMKTS:ORINY Orion OYJ Q3 2024 Earnings Report $39.00 +0.22 (+0.55%) As of 06/17/2026 09:30 AM Eastern ProfileEarnings HistoryForecast Orion OYJ EPS ResultsActual EPS$0.63Consensus EPS N/ABeat/MissN/AOne Year Ago EPSN/AOrion OYJ Revenue ResultsActual Revenue$517.97 millionExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/AOrion OYJ Announcement DetailsQuarterQ3 2024Date10/29/2024TimeN/AConference Call DateN/AConference Call TimeN/AConference Call ResourcesEarnings HistoryCompany Profile Orion OYJ Earnings HeadlinesOrion Oyj Record 2025 Results Put Board Changes And Valuation In FocusFebruary 15, 2026 | finance.yahoo.comDoes Orion Oyj (HLSE:ORNBV) Dividend Hike Clarify Its Oncology-Pivot Capital Allocation Strategy?February 14, 2026 | finance.yahoo.comBuy now or wait?SpaceX may be the biggest IPO in history, but according to Joel Litman - who called AMD before it rose as much as 7,100% - buying SPCX stock isn't the best way to profit. A hidden SpaceX division, already live across the American South and unrelated to its launch business, could be worth 100 times more than SpaceX's core operations. Rob Spivey, Director of Research at Altimetry, breaks down exactly what it is and how to position for it. | Altimetry (Ad)Orion Oyj (ORINY) Q4 2025 Earnings Call Highlights: Record Growth and Strategic DevelopmentsFebruary 12, 2026 | finance.yahoo.comAssessing Orion Oyj (HLSE:ORNBV) Valuation After A Strong 1 Year Shareholder ReturnFebruary 7, 2026 | finance.yahoo.comOrion publishes Financial Statement Release for 2025 and holds a webcast on 12 February 2026January 30, 2026 | uk.finance.yahoo.comSee More Orion OYJ Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Orion OYJ? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Orion OYJ and other key companies, straight to your email. Email Address About Orion OYJOrion Corporation (Orion OYJ (OTCMKTS:ORINY)) is a Finland-based pharmaceutical company engaged in the research, development, manufacture and marketing of human and veterinary medicines as well as diagnostic tests. The company’s core therapeutic areas include central nervous system disorders, oncology and respiratory diseases, and it offers both proprietary and generic products. Orion’s product range spans from small-molecule drugs and active pharmaceutical ingredients to radiodiagnostic imaging agents and line extensions developed through in-house research. Since its founding in 1917 in Helsinki, Orion has grown into an integrated pharmaceuticals business with state-of-the-art manufacturing facilities in Finland and France. The company’s R&D organization focuses on novel chemical entities and life-cycle management of existing products, supported by a network of research partnerships and licensing agreements. In addition to human healthcare, Orion Diagnostica develops and distributes immunoassays and point-of-care tests for clinical and veterinary diagnostics. Orion serves markets across Europe, the Nordic countries and selected regions in Asia and Latin America, leveraging both direct sales operations and partner networks. The company maintains strategic alliances to expand its geographic reach and enhance market access for its specialty products. Orion’s customer base includes hospitals, pharmacies and healthcare professionals, reflecting its long-established presence in the pharmaceutical industry.View Orion OYJ ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Okta’s AI Moment May Be Bigger Than Investors RealizeDave & Buster’s Q1 Miss Raises the Stakes for Its Turnaround PlanMicrosoft’s Xbox Problem Is Bigger Than a Console WarFlying Under the Radar: Lockheed Martin's $2.8B Stealth SetupBread’s Comeback Is Real—But Is the Easy Money Gone?Strategy’s Bitcoin Rally Has a Hidden EngineOllie's Stock Has Lagged Despite Earnings Beats—What's Holding It Back? Upcoming Earnings Accenture (6/18/2026)FedEx (6/23/2026)Micron Technology (6/24/2026)NIKE (6/30/2026)PepsiCo (7/9/2026)Delta Air Lines (7/9/2026)Fastenal (7/13/2026)Bank of America (7/14/2026)The Goldman Sachs Group (7/14/2026)JPMorgan Chase & Co. (7/14/2026) Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
